微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.07% | -2.82% | -75.15% | 51/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 8.33% | 0.36% | 27.18% | 32/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 6.55% | -5.62% | 57.45% | 46/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 4.16% | -2.58% | 95.31% | 42/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 2.13% | -1.39% | -74.34% | 53/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 8.3% | 14.48% | 19.6% | 39/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 6.94% | 33.72% | 62.53% | 51/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 4.27% | 21.31% | 97.69% | 47/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 2.16% | 22.73% | -70.21% | 55/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 7.25% | 12.58% | 39.69% | 44/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 5.19% | -6.99% | 47.44% | 67/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 3.52% | -18.14% | 100% | 60/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 1.76% | -10.66% | -72.67% | 64/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 6.44% | -12.86% | 15.41% | 59/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 5.58% | -11.85% | 29.77% | 59/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 4.3% | 2.14% | 118.27% | 54/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 1.97% | -1.5% | -73.34% | 60/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 7.39% | 6.95% | 16.75% | 62/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 6.33% | 5.5% | 50.36% | 63/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 4.21% | 0.96% | 110.5% | 65/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 2% | -21.88% | -71.06% | 65/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 6.91% | -37.58% | 15.17% | 73/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 6% | -38.52% | 43.88% | 66/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 4.17% | -38.59% | 62.89% | 63/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 2.56% | -33.33% | -76.87% | 40/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 11.07% | -38.5% | 13.42% | 50/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 9.76% | -31.12% | 43.74% | 35/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 6.79% | -34.4% | 76.82% | 31/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 3.84% | 2% | -78.67% | 20/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 18% | -15.41% | 27.03% | 23/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 14.17% | 2% | 36.91% | 12/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 10.35% | -18.5% | -51.36% | 10/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2017-12-31 | 21.28% | -27.12% | 67.56% | 11/157 | 9.62% | 信立泰 | 25.93% | 行业排名> |
| 2017-06-30 | 12.7% | 2% | -56.51% | 6/157 | 5.56% | 昂利康 | 15.91% | 行业排名> |
| 2016-12-31 | 29.2% | 28.98% | 28.98% | 5/157 | 6.05% | 奥赛康 | 12.08% | 行业排名> |